Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Catheter-based therapies for patients with medication-refractory pulmonary arterial hypertension.

Literature DB >> 26553702

Catheter-based therapies for patients with medication-refractory pulmonary arterial hypertension.

Jane A Leopold¹.

Abstract

Entities: Chemical Disease Gene Species

Keywords: denervation; prognosis; pulmonary hypertension; survival rate; vascular resistance

Mesh：

Year: 2015 PMID： 26553702 PMCID： PMC4643383 DOI： 10.1161/CIRCINTERVENTIONS.115.003332

Source DB: PubMed Journal: Circ Cardiovasc Interv ISSN： 1941-7640 Impact factor: 6.546

× No keyword cloud information.

21 in total

1. Potts shunt in patients with pulmonary hypertension.

Authors: Julie Blanc; Pascal Vouhé; Damien Bonnet
Journal: N Engl J Med Date: 2004-02-05 Impact factor: 91.245

Review 2. Percutaneous interventional therapies for the treatment of patients with severe pulmonary hypertension.

Authors: Paul Bhamra-Ariza; Anne M Keogh; David W M Muller
Journal: J Am Coll Cardiol Date: 2013-12-11 Impact factor: 24.094

Review 3. Interventional and surgical therapeutic strategies for pulmonary arterial hypertension: Beyond palliative treatments.

Authors: Julio Sandoval; Jose Gomez-Arroyo; Jorge Gaspar; Tomas Pulido-Zamudio
Journal: J Cardiol Date: 2015-03-11 Impact factor: 3.159

4. Five-Year outcomes of patients enrolled in the REVEAL Registry.

Authors: Harrison W Farber; Dave P Miller; Abby D Poms; David B Badesch; Adaani E Frost; Erwan Muros-Le Rouzic; Alain J Romero; Wade W Benton; C Gregory Elliott; Michael D McGoon; Raymond L Benza
Journal: Chest Date: 2015-10 Impact factor: 9.410

Review 5. Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.

Authors: Bradley A Maron; Jane A Leopold
Journal: Circulation Date: 2015-06-09 Impact factor: 29.690

6. Balloon dilation atrial septostomy for advanced pulmonary hypertension in patients on prostanoid therapy.

Authors: Brooks T Kuhn; Usman Javed; Ehrin J Armstrong; Gagan D Singh; Thomas W Smith; Charles J Whitcomb; Roblee P Allen; Jason H Rogers
Journal: Catheter Cardiovasc Interv Date: 2014-12-10 Impact factor: 2.692

7. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.

Authors: W E Hopkins; L L Ochoa; G W Richardson; E P Trulock
Journal: J Heart Lung Transplant Date: 1996-01 Impact factor: 10.247

8. Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study.

Authors: Shao-Liang Chen; Hang Zhang; Du-Jiang Xie; Juan Zhang; Ling Zhou; Alexander M K Rothman; Gregg W Stone
Journal: Circ Cardiovasc Interv Date: 2015-11 Impact factor: 6.546

9. Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension.

Authors: Alexander M K Rothman; Nadine D Arnold; William Chang; Oliver Watson; Andrew J Swift; Robin Condliffe; Charlie A Elliot; David G Kiely; S Kim Suvarna; Julian Gunn; Allan Lawrie
Journal: Circ Cardiovasc Interv Date: 2015-11 Impact factor: 6.546

Review 10. Pulmonary arterial hypertension in adults: novel drugs and catheter ablation techniques show promise? Systematic review on pharmacotherapy and interventional strategies.

Authors: Salvatore Rosanio; Francesco Pelliccia; Carlo Gaudio; Cesare Greco; Abdul M Keylani; Darrin C D'Agostino
Journal: Biomed Res Int Date: 2014-06-12 Impact factor: 3.411

4 in total

4. Overexpression of microRNA-506-3p aggravates the injury of vascular endothelial cells in patients with hypertension by downregulating Beclin1 expression.

Authors: Fanfan Yi; Yugui Hao; Xiaoyi Chong; Wei Zhong
Journal: Exp Ther Med Date: 2018-01-10 Impact factor: 2.447